Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D P Rossignol

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Lipoprotein distribution of a novel endotoxin antagonist, E5531, in plasma from human subjects with various lipid levelsK M Wasan, F W Strobel, S C Parrott, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
Suppression of murine endotoxin response by E5531, a novel synthetic lipid A antagonistS Kobayashi, T Kawata, A Kimura, et al.
The Journal of Clinical Investigation|June 20, 2001
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantationK R Cooke, A Gerbitz, J M Crawford, et al.
American Journal of Respiratory Cell and Molecular Biology|April 1, 1995
Induction of lipopolysaccharide-binding protein gene expression in cultured rat pulmonary artery smooth muscle cells by interleukin 1 betaH R Wong, B R Pitt, G L Su, et al.
Surgery|August 1, 1994
Suppression of lipopolysaccharide-induced macrophage nitric oxide and cytokine production in vitro by a novel lipopolysaccharide antagonistS C Wang, D P Rossignol, W J Christ, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteinsJ R Rose, M A Mullarkey, W J Christ, et al.
British Journal of Pharmacology|August 5, 1999
E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharideT Kawata, J R Bristol, D P Rossignol, et al.
Biochemical Pharmacology|July 15, 1990
Pumiliotoxin alkaloids: a new class of sodium channel agentsJ W Daly, F Gusovsky, E T McNeal, et al.
Progress in Clinical and Biological Research|January 1, 1995
Anti-endotoxin activity of a novel synthetic lipid A analogT Kawata, J R Bristol, J R Rose, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Lipoprotein distribution of a novel endotoxin antagonist, E5531, in plasma from human subjects with various lipid levelsK M Wasan, F W Strobel, S C Parrott, et al.
Antimicrobial Agents and Chemotherapy|October 31, 1998
Suppression of murine endotoxin response by E5531, a novel synthetic lipid A antagonistS Kobayashi, T Kawata, A Kimura, et al.
The Journal of Clinical Investigation|June 20, 2001
LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantationK R Cooke, A Gerbitz, J M Crawford, et al.
American Journal of Respiratory Cell and Molecular Biology|April 1, 1995
Induction of lipopolysaccharide-binding protein gene expression in cultured rat pulmonary artery smooth muscle cells by interleukin 1 betaH R Wong, B R Pitt, G L Su, et al.
Surgery|August 1, 1994
Suppression of lipopolysaccharide-induced macrophage nitric oxide and cytokine production in vitro by a novel lipopolysaccharide antagonistS C Wang, D P Rossignol, W J Christ, et al.
Antimicrobial Agents and Chemotherapy|February 19, 2000
Consequences of interaction of a lipophilic endotoxin antagonist with plasma lipoproteinsJ R Rose, M A Mullarkey, W J Christ, et al.
British Journal of Pharmacology|August 5, 1999
E5531, a synthetic non-toxic lipid A derivative blocks the immunobiological activities of lipopolysaccharideT Kawata, J R Bristol, D P Rossignol, et al.
Biochemical Pharmacology|July 15, 1990
Pumiliotoxin alkaloids: a new class of sodium channel agentsJ W Daly, F Gusovsky, E T McNeal, et al.
Progress in Clinical and Biological Research|January 1, 1995
Anti-endotoxin activity of a novel synthetic lipid A analogT Kawata, J R Bristol, J R Rose, et al.
Pageof 2